Quarterly ResultJul 29, 2026, 06:31 AM
GE HealthCare Q2 Revenue $5.3B, Organic Growth 3.5%; EPS $1.24
AI Summary
GE HealthCare reported strong second quarter 2026 financial results, with total revenues increasing 5.7% to $5.3 billion and organic revenue growth of 3.5%. Diluted EPS rose 16.5% to $1.24, and the company achieved record organic orders growth of 11.1% and a backlog of $23.9 billion. Despite these gains, the Patient Care Solutions segment continued to be challenged, prompting a review of strategic options. The company reaffirmed its full-year 2026 guidance.
Key Highlights
- Total revenues increased 5.7% to $5.3 billion.
- Organic revenue growth was 3.5%.
- Diluted EPS grew 16.5% to $1.24.
- Record organic orders growth of 11.1% with a $23.9 billion backlog.
- Advanced Imaging Solutions revenue grew 7.9% to $3.77 billion.
- Pharmaceutical Diagnostics revenue grew 15.6% to $843 million.
- Patient Care Solutions revenue declined 13.3% to $675 million.
- Reaffirmed full-year 2026 organic revenue growth guidance of 3.0% to 4.0%.
- Repurchased 3.3 million shares for $200 million.
- Declared a quarterly dividend of $0.035 per share.
Price Impact
More from GEHC